MARK4 inhibitor 1
|
M649512-25mg
|
≥98% |
2271081-58-2 |
25mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
MARK4 inhibitor 1
|
M649512-1mg
|
≥98% |
2271081-58-2 |
1mg
|
¥ 1257.9
|
期货,请咨询 |
阿拉丁 |
MARK4 inhibitor 1
|
M649512-10mg
|
≥98% |
2271081-58-2 |
10mg
|
¥ 4100.9
|
期货,请咨询 |
阿拉丁 |
莫非赛定
|
M649496-5mg
|
≥98% |
1092970-12-1 |
5mg
|
¥ 559.9
|
现货 |
阿拉丁 |
莫非赛定
|
M649496-1mg
|
≥98% |
1092970-12-1 |
1mg
|
¥ 199.9
|
现货 |
阿拉丁 |
莫非赛定
|
M649496-10mg
|
≥98% |
1092970-12-1 |
10mg
|
¥ 734.9
|
现货 |
阿拉丁 |
Methyl rosmarinate
|
M649468-5mg
|
≥99% |
99353-00-1 |
5mg
|
¥ 2350.9
|
期货,请咨询 |
阿拉丁 |
Methyl rosmarinate
|
M649468-10mg
|
≥99% |
99353-00-1 |
10mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Mirificin
|
M649441-5mg
|
≥99% |
103654-50-8 |
5mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
Mirificin
|
M649441-10mg
|
≥99% |
103654-50-8 |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
MS432
|
M649435-5mg
|
≥98% |
2672512-44-4 |
5mg
|
¥ 7000.9
|
期货,请咨询 |
阿拉丁 |
MS432
|
M649435-10mg
|
≥98% |
2672512-44-4 |
10mg
|
¥ 11500.9
|
期货,请咨询 |
阿拉丁 |
Moracin M
|
M649431-5mg
|
≥98% |
56317-21-6 |
5mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
Moracin M
|
M649431-50mg
|
≥98% |
56317-21-6 |
50mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
Moracin M
|
M649431-10mg
|
≥98% |
56317-21-6 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
Moracin M
|
M649431-100mg
|
≥98% |
56317-21-6 |
100mg
|
¥ 9800.9
|
期货,请咨询 |
阿拉丁 |
MS170
|
M649394-5mg
|
≥99% |
2376136-61-5 |
5mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
MS170
|
M649394-1mg
|
≥99% |
2376136-61-5 |
1mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Mal-VC-PAB-DM1
|
M649386-5mg
|
≥99% |
1464051-44-2 |
5mg
|
¥ 9000.9
|
期货,请咨询 |
阿拉丁 |
Mal-VC-PAB-DM1
|
M649386-1mg
|
≥99% |
1464051-44-2 |
1mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
Mal-VC-PAB-DM1
|
M649386-10mg
|
≥99% |
1464051-44-2 |
10mg
|
¥ 13600.9
|
期货,请咨询 |
阿拉丁 |
Methotrexate α-tert-butyl ester
|
M649379-5mg
|
≥96% |
79640-70-3 |
5mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
Methotrexate α-tert-butyl ester
|
M649379-10mg
|
≥96% |
79640-70-3 |
10mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
ML132
|
M649371-5mg
|
≥98% |
1230628-71-3 |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |